Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04508049 · ClinicalTrials.gov registry record · NA

A Study to Evaluate Renal Fibrosis Using MRI Techniques

A NA study of Hypertension and Renovascular, sponsored by Mayo Clinic.

Active
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT04508049 is a NA study of Hypertension and Renovascular that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 24 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04508049, a NA study of Hypertension and Renovascular, is active but no longer recruiting, sponsored by Mayo Clinic.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate whether or not an MRI technique (quantitative magnetization transfer or qMT) in narrowing human kidneys is feasible, reproducible, and predicts recovery.

Interventions

  • DEVICE qMT-MRI to detect fibrosis.

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2020-10-01
Est. Completion 2026-12
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT04508049

The ClinicalTrials.gov registry entry for NCT04508049 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which qMT-MRI to detect fibrosis. is the first listed.

NCT04508049 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT04508049 about?

NCT04508049 is a clinical study titled "A Study to Evaluate Renal Fibrosis Using MRI Techniques". The purpose of this study is to evaluate whether or not an MRI technique (quantitative magnetization transfer or qMT) in narrowing human kidneys is feasible, reproducible, and predicts recovery.

What is the current status of trial NCT04508049?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2020-10-01. Estimated completion is 2026-12.

What conditions does trial NCT04508049 study?

This clinical trial studies the following conditions: Hypertension, Renovascular.

What interventions are being tested in trial NCT04508049?

The interventions under investigation include: qMT-MRI to detect fibrosis. (DEVICE).

Who is sponsoring clinical trial NCT04508049?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04508049 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.